BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31398791)

  • 1. Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
    Mouzat K; Chudinova A; Polge A; Kantar J; Camu W; Raoul C; Lumbroso S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
    Mouzat K; Raoul C; Polge A; Kantar J; Camu W; Lumbroso S
    Cell Mol Life Sci; 2016 Oct; 73(20):3801-8. PubMed ID: 27510420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR Regulation of Brain Cholesterol: From Development to Disease.
    Courtney R; Landreth GE
    Trends Endocrinol Metab; 2016 Jun; 27(6):404-414. PubMed ID: 27113081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols, cholesterol homeostasis, and Alzheimer disease.
    Vaya J; Schipper HM
    J Neurochem; 2007 Sep; 102(6):1727-1737. PubMed ID: 17573819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Brain Liver X Receptor in Parkinson's Disease: Hidden Treasure and Emerging Opportunities.
    Alnaaim SA; Al-Kuraishy HM; Alexiou A; Papadakis M; Saad HM; Batiha GE
    Mol Neurobiol; 2024 Jan; 61(1):341-357. PubMed ID: 37606719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?
    Pineda-Torra I; Siddique S; Waddington KE; Farrell R; Jury EC
    Front Endocrinol (Lausanne); 2021; 12():639757. PubMed ID: 33927692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol, Oxysterols and LXRs in Breast Cancer Pathophysiology.
    Nazih H; Bard JM
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestenoic acid analogues as inverse agonists of the liver X receptors.
    Alvarez LD; Dansey MV; Ogara MF; Peña CI; Houtman R; Veleiro AS; Pecci A; Burton G
    J Steroid Biochem Mol Biol; 2020 May; 199():105585. PubMed ID: 31931135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases.
    Ma Z; Deng C; Hu W; Zhou J; Fan C; Di S; Liu D; Yang Y; Wang D
    Curr Issues Mol Biol; 2017; 22():41-64. PubMed ID: 27669666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXR agonists: new potential therapeutic drug for neurodegenerative diseases.
    Xu P; Li D; Tang X; Bao X; Huang J; Tang Y; Yang Y; Xu H; Fan X
    Mol Neurobiol; 2013 Dec; 48(3):715-28. PubMed ID: 23625315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X Receptors and Male (In)fertility.
    Jarvis S; Williamson C; Bevan CL
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxysterol derivatives of cholesterol in neurodegenerative disorders.
    Jeitner TM; Voloshyna I; Reiss AB
    Curr Med Chem; 2011; 18(10):1515-25. PubMed ID: 21428891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol and oxysterol sulfates: Pathophysiological roles and analytical challenges.
    Sanchez LD; Pontini L; Marinozzi M; Sanchez-Aranguren LC; Reis A; Dias IHK
    Br J Pharmacol; 2021 Aug; 178(16):3327-3341. PubMed ID: 32762060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions.
    Deshwal S; Baidya AT; Kumar R; Sandhir R
    J Steroid Biochem Mol Biol; 2022 Oct; 223():106150. PubMed ID: 35787453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system.
    Maqdasy S; Trousson A; Tauveron I; Volle DH; Baron S; Lobaccaro JM
    Mol Aspects Med; 2016 Jun; 49():31-46. PubMed ID: 27091047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.
    Zelcer N; Khanlou N; Clare R; Jiang Q; Reed-Geaghan EG; Landreth GE; Vinters HV; Tontonoz P
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10601-6. PubMed ID: 17563384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor in cholesterol metabolism.
    Zhao C; Dahlman-Wright K
    J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
    Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.